Omar Kabbarah

2.6k total citations
41 papers, 1.4k citations indexed

About

Omar Kabbarah is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Omar Kabbarah has authored 41 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 15 papers in Cancer Research and 14 papers in Molecular Biology. Recurrent topics in Omar Kabbarah's work include Colorectal Cancer Treatments and Studies (14 papers), Genetic factors in colorectal cancer (12 papers) and Cancer Genomics and Diagnostics (11 papers). Omar Kabbarah is often cited by papers focused on Colorectal Cancer Treatments and Studies (14 papers), Genetic factors in colorectal cancer (12 papers) and Cancer Genomics and Diagnostics (11 papers). Omar Kabbarah collaborates with scholars based in United States, Switzerland and Belgium. Omar Kabbarah's co-authors include Xueping Qu, Lynda Chin, Fang‐Shu Ou, Alan P. Venook, Federico Innocenti, Heinz‐Josef Lenz, Charles D. Blanke, Donna Niedzwiecki, Tyler Zemla and Richard M. Goldberg and has published in prestigious journals such as Nature, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Omar Kabbarah

37 papers receiving 1.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Omar Kabbarah	772	608	395	339	292	41	1.4k
Joost S.P. Vermaat	705 0.9×	735 1.2×	383 1.0×	493 1.5×	186 0.6×	72	1.5k
Chee Wee Ong	679 0.9×	833 1.4×	148 0.4×	335 1.0×	308 1.1×	33	1.5k
Anne Trinh	860 1.1×	554 0.9×	471 1.2×	477 1.4×	214 0.7×	26	1.4k
Ian A.J. Lorimer	515 0.7×	699 1.1×	132 0.3×	395 1.2×	302 1.0×	41	1.3k
Pramudita R. Prasetyanti	937 1.2×	890 1.5×	238 0.6×	495 1.5×	181 0.6×	14	1.6k
Parham Minoo	804 1.0×	629 1.0×	573 1.5×	173 0.5×	195 0.7×	38	1.5k
Giorgia Migliardi	710 0.9×	507 0.8×	178 0.5×	274 0.8×	346 1.2×	28	1.3k
Elisa Espinet	1.3k 1.7×	926 1.5×	292 0.7×	585 1.7×	257 0.9×	18	2.0k
Dexter X. Jin	734 1.0×	561 0.9×	289 0.7×	424 1.3×	354 1.2×	46	1.4k
Angelica Fasolo	835 1.1×	655 1.1×	183 0.5×	282 0.8×	382 1.3×	43	1.4k

Countries citing papers authored by Omar Kabbarah

Since Specialization

Citations

This map shows the geographic impact of Omar Kabbarah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omar Kabbarah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omar Kabbarah more than expected).

Fields of papers citing papers by Omar Kabbarah

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omar Kabbarah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omar Kabbarah. The network helps show where Omar Kabbarah may publish in the future.

Co-authorship network of co-authors of Omar Kabbarah

This figure shows the co-authorship network connecting the top 25 collaborators of Omar Kabbarah. A scholar is included among the top collaborators of Omar Kabbarah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omar Kabbarah. Omar Kabbarah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Battaglin, Francesca, Fang‐Shu Ou, Xueping Qu, et al.. (2024). HER2 Gene Expression Levels Are Predictive and Prognostic in Patients With Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405. Journal of Clinical Oncology. 42(16). 1890–1902. 6 indexed citations

Kim, Ji Yun, Ning Wang, Benjamin R. Weeder, et al.. (2024). Abstract C007: Quemliclustat (CD73 Inhibitor) reduces adenosine-regulated NR4A gene expression and increases mPDAC inflammation in patients from the ARC-8 trial. Cancer Research. 84(17_Supplement_2). C007–C007.

Szeto, Christopher W., Renyi Wu, Fang Xu, et al.. (2022). CD47-blocking Antibody ZL-1201 Promotes Tumor-associated Macrophage Phagocytic Activity and Enhances the Efficacy of the Therapeutic Antibodies and Chemotherapy. Cancer Research Communications. 2(11). 1404–1417. 10 indexed citations

Johnson, Radia Marie, Xueping Qu, Ling‐Yuh Huw, et al.. (2022). ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer. Nature Communications. 13(1). 5478–5478. 21 indexed citations

Daemen, Anneleen, Thomas Sandmann, Congfen Li, et al.. (2021). Transcriptomic profiling of adjuvant colorectal cancer identifies three key prognostic biological processes and a disease specific role for granzyme B. PLoS ONE. 16(12). e0262198–e0262198. 4 indexed citations

Zhou, Haiying, Qiuping Ye, Aleksandr Pankov, et al.. (2020). Abstract P6-03-24: ORIC-101 robustly inhibits the glucocorticoid pathway and overcomes chemoresistance in triple-negative breast cancer. Cancer Research. 80(4_Supplement). P6–3.

Pankov, Aleksandr, Haiying Zhou, Ganapati V. Hegde, et al.. (2020). Abstract 4120: ORIC-101 comprehensively inhibits glucocorticoid pathways to overcome therapeutic resistance in pan-cancer models. Cancer Research. 80(16_Supplement). 4120–4120.

Piskol, Robert, Ling Huw, Ismail Sergin, et al.. (2019). A Clinically Applicable Gene-Expression Classifier Reveals Intrinsic and Extrinsic Contributions to Consensus Molecular Subtypes in Primary and Metastatic Colon Cancer. Clinical Cancer Research. 25(14). 4431–4442. 37 indexed citations

Lenz, Heinz‐Josef, Fang‐Shu Ou, Alan P. Venook, et al.. (2019). Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance). Journal of Clinical Oncology. 37(22). 1876–1885. 159 indexed citations

10.

Sandhu, Shahneen, Catriona M. McNeil, Patricia LoRusso, et al.. (2019). Phase I study of the anti-endothelin B receptor antibody-drug conjugate DEDN6526A in patients with metastatic or unresectable cutaneous, mucosal, or uveal melanoma. Investigational New Drugs. 38(3). 844–854. 23 indexed citations

11.

Qu, Xueping, Thomas Sandmann, Henry F. Frierson, et al.. (2016). Integrated genomic analysis of colorectal cancer progression reveals activation of EGFR through demethylation of the EREG promoter. Oncogene. 35(50). 6403–6415. 56 indexed citations

12.

Danila, Daniel C., Russell Z. Szmulewitz, Celestia S. Higano, et al.. (2013). A phase I study of the safety and pharmacokinetics of DSTP3086S, an anti-STEAP1 antibody-drug conjugate (ADC), in patients (pts) with metastatic castration-resistant prostate cancer (CRPC).. Journal of Clinical Oncology. 31(15_suppl). 5020–5020. 13 indexed citations

13.

Scott, Kenneth L., Omar Kabbarah, Mei‐Chih Liang, et al.. (2009). GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer. Nature. 459(7250). 1085–1090. 294 indexed citations

14.

Kabbarah, Omar, Mary A. Mallon, John D. Pfeifer, & Paul J. Goodfellow. (2006). Transcriptional profiling endometrial carcinomas microdissected from DES‐treated mice identifies changes in gene expression associated with estrogenic tumor promotion. International Journal of Cancer. 119(8). 1843–1849. 8 indexed citations

15.

Kabbarah, Omar. (2006). Advances in malignant melanoma: genetic insights from mouse and man. Frontiers in bioscience. 11(1). 928–928. 11 indexed citations

16.

Kabbarah, Omar & Lynda Chin. (2005). Revealing the genomic heterogeneity of melanoma. Cancer Cell. 8(6). 439–441. 32 indexed citations

17.

Kabbarah, Omar, Mary A. Mallon, Mingyu Fan, et al.. (2005). Diethylstilbestrol effects and lymphomagenesis in Mlh1‐deficient mice. International Journal of Cancer. 115(4). 666–669. 8 indexed citations

18.

Kabbarah, Omar, Mary A. Mallon, John D. Pfeifer, et al.. (2003). A panel of repeat markers for detection of microsatellite instability in murine tumors. Molecular Carcinogenesis. 38(4). 155–159. 27 indexed citations

19.

Gutmann, David H., Omar Kabbarah, Nicolé M. Hedrick, et al.. (2003). Mlh1 deficiency accelerates myeloid leukemogenesis in neurofibromatosis 1 (Nf1) heterozygous mice. Oncogene. 22(29). 4581–4585. 18 indexed citations

20.

Kabbarah, Omar, Karen Pinto, David G. Mutch, & Paul J. Goodfellow. (2003). Expression Profiling of Mouse Endometrial Cancers Microdissected from Ethanol-Fixed, Paraffin-Embedded Tissues. American Journal Of Pathology. 162(3). 755–762. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact